OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prolactin: The Third Hormone in Breast Cancer
Linda A. Schuler, Kathleen A. O’Leary
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers
Cassandra A. Hathaway, Megan S. Rice, Laura C. Collins, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 27

Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies
David Standing, Prasad Dandawate, Shrikant Anant
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 25

Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case–Control Database Study
Marco Solmi, Markku Lähteenvuo, Antti Tanskanen, et al.
Schizophrenia Bulletin (2024) Vol. 50, Iss. 6, pp. 1471-1481
Open Access | Times Cited: 10

Elucidating the mechanism of plasticizers inducing breast cancer through network toxicology and molecular docking analysis
Na He, Chenning Zhang, Ming-Yu Liu, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 284, pp. 116866-116866
Open Access | Times Cited: 8

Sex-specific outcomes in cancer therapy: the central role of hormones
Parisa Bakhshi, Jim Q. Ho, Saeid Zanganeh
Frontiers in Medical Technology (2024) Vol. 6
Open Access | Times Cited: 4

Resistant PRL-secreting PitNET associated with breast carcinoma: a case report and literature review
Roxana-Ioana Dumitriu-Stan, Iulia Florentina Burcea, Valeria Nicoleta Nastase, et al.
International Cancer Conference Journal (2025) Vol. 14, Iss. 2, pp. 97-106
Open Access

A role for JAK2 in mediating cell surface GHR-PRLR interaction
Chen Chen, Jing Jiang, Tejeshwar C. Rao, et al.
(2025)
Open Access

Prolactin as a novel biomarker in malignancy
Sahel Safdari, Sahel Safdari, Parisa Noorabadi
Clinica Chimica Acta (2025), pp. 120277-120277
Closed Access

Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not
Xiaoyun Tang, Andrew J. Morris, Marcel A. Deken, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2937-2937
Open Access | Times Cited: 9

In silico identification and in vitro evaluation of MRPS30‐DT lncRNA and MRPS30 gene expression in breast cancer
Nooshafarin Shirani, Roohallah Mahdi‐Esferizi, Reza Eshraghi Samani, et al.
Cancer Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 3

Breast cancer status, grading system, etiology, and challenges in Asia: an updated review
Xiao Jian Tan, Wai Loon Cheor, Ee Meng Cheng, et al.
ONCOLOGIE (2023) Vol. 25, Iss. 2, pp. 99-110
Open Access | Times Cited: 6

Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs
Joshua Watson, Tianfang Wang, Kun-Lin Ho, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 5

Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates
Reetobrata Basu, Rich Brody, Uday Sandbhor, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 105030-105030
Open Access | Times Cited: 5

Association between prolactin/testosterone ratio and breast cancer in Chinese women
Qian Cai, Xiaohan Tian, Yuyi Tang, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 3, pp. 368-370
Open Access | Times Cited: 1

Mild hyperprolactinemia in clinical practice: the diagnostic “traps” and treatment strategy
Irena Ilovayskaya, E. V. Kruchinina
Almanac of Clinical Medicine (2024) Vol. 52, Iss. 1, pp. 45-54
Open Access | Times Cited: 1

Beyond Milk and Nurture: Breastfeeding’s Powerful Impact on Breast Cancer
Muhammad Mustafa, Sadaf Sarfraz, Gullelalah Saleem, et al.
Geburtshilfe und Frauenheilkunde (2024) Vol. 84, Iss. 06, pp. 541-554
Open Access | Times Cited: 1

Breast Cancer risk in patients with dopamine agonist-treated hyperprolactinemia
Laura Dery, Ilan Shimon, Yaron Rudman, et al.
Journal of Endocrinological Investigation (2024)
Closed Access | Times Cited: 1

Safety of lactational exposure to venlafaxine on the rat mammary gland development and carcinogenesis in F1 female offspring
Marcelo Augusto Altieri, Anielly Sarana da Silva, Suyane da Silva Moreira, et al.
Reproductive Toxicology (2023) Vol. 120, pp. 108451-108451
Closed Access | Times Cited: 2

A role for JAK2 in mediating cell surface GHR-PRLR interaction
Chen Chen, Jing Jiang, Tejeshwar C. Rao, et al.
(2023)
Open Access | Times Cited: 1

Research Progress on the Relationship between Prolactin and Maternal Lactation
星星 李
Nursing Science (2024) Vol. 13, Iss. 02, pp. 141-148
Closed Access

Simultaneous Detection of Prolactin and Growth Hormone Using a Dual-label Time-resolved Fluorescence Immunoassay
Shuhai Zhong, Huankun Liang, Fenglan Peng, et al.
Journal of Fluorescence (2024)
Closed Access

Prolactin-induced tyrosyl phosphorylation of PAK1 facilitates epithelial-mesenchymal transition.
Alan Hammer, Maria Diakonova
PubMed (2024) Vol. 2024
Closed Access

ВПЛИВ АНТИДЕПРЕСАНТІВ НА РИЗИК УТВОРЕННЯ КІСТ У МОЛОЧНИХ ЗАЛОЗАХ ТА ЯЄЧНИКАХ
Тамара Воронцова, Світлана Кучер, Віталій Ткачук, et al.
Перспективи та інновації науки (2024), Iss. 5(39)
Open Access

Page 1 - Next Page

Scroll to top